2012 annual financial data
Viridian Therapeutics 2012 Net margin
Direct answer
Net margin was -163.67%.
Operating income was -4,027,000 USD and net income was -7,211,285 USD.
Operating cash flow was -6,224,802 USD.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,406,042 USD
- Operating income
- -4,027,000 USD
- Net income
- -7,211,285 USD
- Operating cash flow
- -6,224,802 USD
Explore related company data
View all 2012 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Viridian Therapeutics financial years